Go Pro
→ MILLIONAIRE MASTERCLASS INVITE: Altucher (From Paradigm Press) (Ad)tc pixel Free UTRS Stock Alerts

Minerva Surgical (UTRS) Competitors

Minerva Surgical logo
Compare

UTRS vs. AFIB, MOTS, DRTSW, BDMDW, and COCHW

Should you buy Minerva Surgical stock or one of its competitors? Minerva Surgical's main competitors and comparable companies include Acutus Medical (AFIB), Motus GI (MOTS), Alpha Tau Medical (DRTSW), Baird Medical Investment (BDMDW), and Envoy Medical (COCHW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Minerva Surgical compare to Acutus Medical?

Acutus Medical (NASDAQ:AFIB) and Minerva Surgical (NASDAQ:UTRS) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment and dividends.

56.9% of Acutus Medical shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by insiders. Comparatively, 8.5% of Minerva Surgical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Minerva Surgical has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Minerva Surgical's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
Minerva Surgical N/A N/A N/A

Acutus Medical has a beta of 5.73, indicating that its share price is 473% more volatile than the broader market. Comparatively, Minerva Surgical has a beta of 2.41, indicating that its share price is 141% more volatile than the broader market.

Minerva Surgical has higher revenue and earnings than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A
Minerva Surgical$51.69M0.00-$34.11M-$1.81N/A

In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled Minerva Surgical'saverage media sentiment score.

Company Overall Sentiment
Acutus Medical Neutral
Minerva Surgical Neutral

Summary

Minerva Surgical beats Acutus Medical on 7 of the 10 factors compared between the two stocks.

How does Minerva Surgical compare to Motus GI?

Minerva Surgical (NASDAQ:UTRS) and Motus GI (NASDAQ:MOTS) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership.

20.1% of Motus GI shares are owned by institutional investors. 8.5% of Minerva Surgical shares are owned by company insiders. Comparatively, 0.3% of Motus GI shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Motus GI N/A N/A N/A

Motus GI has lower revenue, but higher earnings than Minerva Surgical. Motus GI is trading at a lower price-to-earnings ratio than Minerva Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$1.81N/A
Motus GI$319K0.00-$12.87M-$14.69N/A

In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled Motus GI'saverage media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
Motus GI Neutral

Minerva Surgical has a beta of 2.41, suggesting that its share price is 141% more volatile than the broader market. Comparatively, Motus GI has a beta of 0.81, suggesting that its share price is 19% less volatile than the broader market.

Summary

Minerva Surgical beats Motus GI on 4 of the 7 factors compared between the two stocks.

How does Minerva Surgical compare to Alpha Tau Medical?

Minerva Surgical (NASDAQ:UTRS) and Alpha Tau Medical (NASDAQ:DRTSW) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, valuation, dividends, profitability, risk, earnings, analyst recommendations and institutional ownership.

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

In the previous week, Alpha Tau Medical's average media sentiment score of 0.21 beat Minerva Surgical's score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Minerva Surgical Neutral
Alpha Tau Medical Neutral

Alpha Tau Medical has lower revenue, but higher earnings than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$1.81N/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

Summary

Minerva Surgical and Alpha Tau Medical tied by winning 1 of the 2 factors compared between the two stocks.

How does Minerva Surgical compare to Baird Medical Investment?

Minerva Surgical (NASDAQ:UTRS) and Baird Medical Investment (NASDAQ:BDMDW) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings, profitability and media sentiment.

Baird Medical Investment has lower revenue, but higher earnings than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$1.81N/A
Baird Medical Investment$24.49MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Baird Medical Investment N/A N/A N/A

In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled Baird Medical Investment'saverage media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
Baird Medical Investment Neutral

Summary

Minerva Surgical beats Baird Medical Investment on 1 of the 1 factors compared between the two stocks.

How does Minerva Surgical compare to Envoy Medical?

Minerva Surgical (NASDAQ:UTRS) and Envoy Medical (NASDAQ:COCHW) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership.

In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled Envoy Medical'saverage media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
Envoy Medical Neutral

Envoy Medical has lower revenue, but higher earnings than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$1.81N/A
Envoy Medical$207KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Envoy Medical N/A N/A N/A

Summary

Minerva Surgical beats Envoy Medical on 1 of the 1 factors compared between the two stocks.

Get Minerva Surgical News Delivered to You Automatically

Sign up to receive the latest news and ratings for UTRS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UTRS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UTRS vs. The Competition

Export
MetricMinerva SurgicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1K$5.58B$7.31B$13.29B
Dividend YieldN/A1.79%2.52%12.57%
P/E Ratio0.0025.26274.0825.69
Price / SalesN/A71.56638.2178.99
Price / CashN/A33.0277.8052.76
Price / BookN/A5.7810.476.32
Net Income-$34.11M$151.55M$3.49B$359.73M

Minerva Surgical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UTRS
Minerva Surgical
N/AN/AN/AN/A$1K$51.69MN/A174
AFIB
Acutus Medical
N/A$0.00
flat		N/AN/A$3K$7.16MN/A340
MOTS
Motus GI
N/A$0.00
flat		N/AN/A$1K$319KN/A30
DRTSW
Alpha Tau Medical
N/A$3.74
-2.6%		N/A+1,046.1%$0.00N/AN/A80
BDMDW
Baird Medical Investment
N/A$0.04
flat		N/A-52.4%$0.00$24.49MN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:UTRS) was last updated on 9/24/2026 by MarketBeat.com Staff.
From Our Partners
How to get a stake in Anthropic — before the IPO
Anthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...
Weiss Ratings | Sponsoredtc pixel
Why I believe the AI market will split in Q4
Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...
The Oxford Club | Sponsoredtc pixel
If you keep cash in a U.S. bank account… read this NOW
Since 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...
Banyan Hill Publishing | Sponsoredtc pixel
Shocking new footage just released
Gerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...
Digest Publishing | Sponsoredtc pixel
Major Buy Alert Issued for September 30th
Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...
TradeSmith | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
On October 7th, your “safest” assets are at risk
Jeff Brown called Nvidia's rise of over 27,000 percent and warned in early 2024 that inflation would outlast W...
Brownstone Research | Sponsoredtc pixel
While SpaceX Gets the Spotlight, FJET Is Building What Comes Next!
Starfighters Space (NYSE: FJET) operates the world's only commercial fleet of flight-ready Mach 2+ F-104 Starf...
Trading Wire | Sponsoredtc pixel